| 摘要 |
A new solid or liquid dosage form containing deglycyrrhizinated licorice (DGL) has been designed. This form is more suitable for administration to humans than the form previously used because: (1) irritating ingredients, previously included, possessing no activity, have been removed, (2) bulky, ineffective quantities of antacids have been removed, thereby allowing the amount of the active ingredient DGL to be increased per unit, reducing the number of units needed to be consumed (e.g. from 8 to 4 per day), (3) dangerous, neurotoxic ingredients have been removed, and (4) the bitter DGL has been formulated into an acceptable pharmaceutical dosage form that does not need to be chewed because, unlike other formulations, this formulation is formulated in a novel way that allows for complete and rapid disintegration, releasing the active ingredient in a fashion superior to chewing. |
